At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
INVO INVO BioScience, Inc.
Not Yet Opened 10-21 16:00:00 EDT
0.8330
+0.0000
0.00%
High0.8330Low0.8330Vol0.00
Open0.8330D1 Closing0.8330Amplitude0.00%
Mkt Cap3.25MTradable Cap3.23MTotal Shares3.91M
T/O105.54KT/O Rate0.00%Tradable Shares3.88M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
BRIEF-Invo Bioscience Confirms Corporate Name Change And New Trading Symbol
Reuters  ·  10-21
BRIEF-Invo Bioscience Confirms Corporate Name Change And New Trading Symbol
INVO Bioscience confirms name change, new trading symbol following NAYA merger
TIPRANKS  ·  10-21
INVO Bioscience confirms name change, new trading symbol following NAYA merger
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection With Its Recent Merger With Naya Biosciences
THOMSON REUTERS  ·  10-21
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection With Its Recent Merger With Naya Biosciences
Naya Biosciences Inc - to Trade Under New Symbol 'Naya' From Oct 22
THOMSON REUTERS  ·  10-21
Naya Biosciences Inc - to Trade Under New Symbol 'Naya' From Oct 22
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
GlobeNewswire  ·  10-21
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
INVO Bioscience Completes Merger with NAYA Biosciences
TIPRANKS  ·  10-15
INVO Bioscience Completes Merger with NAYA Biosciences
INVO Bioscience Completes Merger With NAYA Biosciences Acquisition
MT Newswires Live  ·  10-14
INVO Bioscience Completes Merger With NAYA Biosciences Acquisition
INVO Bioscience, NAYA Biosciences close merger
TIPRANKS  ·  10-14
INVO Bioscience, NAYA Biosciences close merger
Press Release: INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
Dow Jones  ·  10-14
Press Release: INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
INVO Bioscience Risks Nasdaq Delisting Amid Stock Price Woes
TIPRANKS  ·  09-21
INVO Bioscience Risks Nasdaq Delisting Amid Stock Price Woes
BRIEF-INVO - Entered Fourth Amendment To Previously Announced Agreement & Plan Of Merger By INVO Merger Sub And NAYA Biosciences
Reuters  ·  09-19
BRIEF-INVO - Entered Fourth Amendment To Previously Announced Agreement & Plan Of Merger By INVO Merger Sub And NAYA Biosciences
INVO Bioscience Inc -Pursuant to Fourth Amendment, Agreed to Extend End Date of Merger to October 14
THOMSON REUTERS  ·  09-19
INVO Bioscience Inc -Pursuant to Fourth Amendment, Agreed to Extend End Date of Merger to October 14
INVO Bioscience- Entered Fourth Amendment to Previously Announced Agreement & Plan of Merger by INVO Merger Sub and Naya Biosciences
THOMSON REUTERS  ·  09-19
INVO Bioscience- Entered Fourth Amendment to Previously Announced Agreement & Plan of Merger by INVO Merger Sub and Naya Biosciences
INVO BioScience GAAP EPS of -$0.62, revenue of $1.84M
seekingalpha  ·  08-16
INVO BioScience GAAP EPS of -$0.62, revenue of $1.84M
INVO BioScience Q2 EPS $(0.62) Up From $(3.06) YoY; Revenue $1.826M Up From $315,902 YoY
Benzinga  ·  08-14
INVO BioScience Q2 EPS $(0.62) Up From $(3.06) YoY; Revenue $1.826M Up From $315,902 YoY
Press Release: INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
Dow Jones  ·  08-14
Press Release: INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
BRIEF-Invo Bioscience On June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request For Continued Listing On Nasdaq
Reuters  ·  06-21
BRIEF-Invo Bioscience On June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request For Continued Listing On Nasdaq
INVO Bioscience: on June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request for Continued Listing on Nasdaq
THOMSON REUTERS  ·  06-21
INVO Bioscience: on June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request for Continued Listing on Nasdaq
The Fastest Declining Large City In The US
Insider Monkey  ·  06-03
The Fastest Declining Large City In The US
INVO Bioscience Inc :Invo Bioscience Inc Files For Mixed Shelf Of Up To $100 Million - Sec Filing.
THOMSON REUTERS  ·  05-22
INVO Bioscience Inc :Invo Bioscience Inc Files For Mixed Shelf Of Up To $100 Million - Sec Filing.
No data available

Introduction

Company Name.
INVO BioScience, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.
Issue price:
--